Many who received the shot may need to consider boosters, the authors said. But federal health officials do not recommend second doses. Source: New York Times
Posts published in “AstraZeneca PLC”
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccine
By Gotham Rex on July 8, 2021
Scientists were critical of the announcement, pointing to evidence that the current two-dose regimen is powerfully effective against the coronavirus. Source: New York Times
Three Studies, One Result: Vaccines Point the Way Out of the Pandemic
By Gotham Rex on June 28, 2021
New scientific research underscores the effectiveness of vaccines and their versatility in the fight against the coronavirus. Source: New York Times
Vaccines Are Effective Against the New York Variant, Studies Find
By Gotham Rex on April 22, 2021
The research adds to a growing number of findings suggesting the Pfizer and Moderna shots are protective against the variants identified so far. Source: New York Times
The Pfizer-BioNTech Vaccine Is Said to Be Powerfully Protective in Adolescents
By Gotham Rex on March 31, 2021
A clinical trial found no symptomatic infections among vaccinated children ages 12 to 15, the companies said, and there were no serious side effects. The data have not yet been reviewed by independent experts. Source: New York Times
As Rollout Falters, Scientists Debate New Vaccination Tactics
By Gotham Rex on January 3, 2021
Should second doses be delayed? Should most adults receive half-doses? Scientists are pondering ways to get more shots into more arms. Source: New York Times
AstraZeneca Partly Resumes Coronavirus Vaccine Trial After Halting It for Safety
By Gotham Rex on September 12, 2020
The company said tests of its vaccine would start up again in Britain while remaining suspended in the U.S. and other countries. Pfizer, a competitor, announced an expansion of its trials. Source: New York Times
Safety Review Begins Into AstraZeneca's Coronavirus Vaccine Trial
By Gotham Rex on September 10, 2020
A participant in the company’s late-stage coronavirus vaccine trial reportedly developed severe neurological symptoms. Now experts must assess whether the vaccine was responsible. Source: New York Times